Recent Finacing
Recent Raise
NeuroNOS develops a small-molecule therapeutic from Hebrew University technology for ASD and neurological conditions, optimizing subcutaneous and oral formulations, initially pursuing subcutaneous pediatric delivery; Boston-based.
